TXMD
TherapeuticsMD Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.17
-0.11 ▼ -4.82%
🌙 3월 13일 6:05 PM ET (한국 3/14 07:05)
$2.17
+0.00 +0.01%
| Index | - | P/E | 83.14 | EPS (ttm) | 0.03 | Insider Own | 1.62% | Shs Outstand | 0.01B | Perf Week | -3.56% |
| Market Cap | 0.03B | Forward P/E | - | EPS next Y | - | Insider Trans | 4.69% | Shs Float | 0.01B | Perf Month | -10.7% |
| Enterprise Value | 0.02B | PEG | - | EPS next Q | - | Inst Own | 29.25% | Short Float | 0.4% | Perf Quarter | 15.43% |
| Income | 0.00B | P/S | 8.97 | EPS this Y | - | Inst Trans | 0.79% | Short Ratio | 0.54 | Perf Half Y | 95.5% |
| Sales | 0.00B | P/B | 0.92 | EPS next 5Y | - | ROA | 0.19% | Short Interest | 0.05M | Perf YTD | 33.13% |
| Book/sh | 2.37 | P/C | 3.53 | EPS past 3/5Y | 79.41% 64.95% | ROE | 0.27% | 52W High | -26.44% ($2.95) | Perf Year | 194.56% |
| Cash/sh | 0.62 | P/FCF | 12.14 | Sales past 3/5Y | -11.87% -48.72% | ROIC | 0.92% | 52W Low | 201.39% ($0.72) | Perf 3Y | -43.78% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 109.08% | Gross Margin | 86.16% | Volatility(W/M) | 3.88% 5.26% | Perf 5Y | -97.27% |
| Dividend TTM | - | EV/Sales | 8.74 | Sales Y/Y TTM | 75.19% | Oper. Margin | -93.71% | ATR (14) | 0.14 | Perf 10Y | -99.36% |
| Dividend Ex-Date | - | Quick Ratio | 2.46 | EPS Q/Q | 124.81% | Profit Margin | 10.8% | RSI (14) | 43.16 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.46 | Sales Q/Q | 43.33% | SMA20 | -4.3% ($2.27) | Beta | 0.51 | Target Price | $5 |
| Payout | - | Debt/Eq | 0.24 | Earnings | 11000000 | SMA50 | -3.55% ($2.25) | Rel Volume | 0.26 | Prev Close | $2.28 |
| Employees | 1 | LT Debt/Eq | 0.2 | EPS/Sales Surpr. | - | SMA200 | 43.5% ($1.51) | Avg Volume(3M) | 0.08M | Price | $2.17 |
| IPO | 2002/1/3 | Option/Short | Yes/Yes | Trades | 220 | Volume | 21,255 | Change | -4.82% |
뉴스 로딩 중...